- Home
- AYRO vs CHEK Comparison
AYRO vs CHEK Comparison
Compare AYRO & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYRO
- CHEK
- Stock Information
- Founded
- AYRO 2017
- CHEK 2004
- Country
- AYRO United States
- CHEK Israel
- Employees
- AYRO N/A
- CHEK N/A
- Industry
- AYRO Telecommunications Equipment
- CHEK Medical Electronics
- Sector
- AYRO Consumer Discretionary
- CHEK Health Care
- Exchange
- AYRO Nasdaq
- CHEK Nasdaq
- Market Cap
- AYRO 4.1M
- CHEK 4.0M
- IPO Year
- AYRO N/A
- CHEK 2015
- Fundamental
- Price
- AYRO $0.51
- CHEK $0.65
- Analyst Decision
- AYRO
- CHEK
- Analyst Count
- AYRO 0
- CHEK 0
- Target Price
- AYRO N/A
- CHEK N/A
- AVG Volume (30 Days)
- AYRO 144.1K
- CHEK 22.2K
- Earning Date
- AYRO 05-14-2025
- CHEK 05-14-2025
- Dividend Yield
- AYRO N/A
- CHEK N/A
- EPS Growth
- AYRO N/A
- CHEK N/A
- EPS
- AYRO N/A
- CHEK N/A
- Revenue
- AYRO $63,777.00
- CHEK N/A
- Revenue This Year
- AYRO N/A
- CHEK N/A
- Revenue Next Year
- AYRO N/A
- CHEK N/A
- P/E Ratio
- AYRO N/A
- CHEK N/A
- Revenue Growth
- AYRO N/A
- CHEK N/A
- 52 Week Low
- AYRO $0.38
- CHEK $0.56
- 52 Week High
- AYRO $1.48
- CHEK $3.04
- Technical
- Relative Strength Index (RSI)
- AYRO 48.89
- CHEK 39.23
- Support Level
- AYRO $0.48
- CHEK $0.65
- Resistance Level
- AYRO $0.57
- CHEK $0.67
- Average True Range (ATR)
- AYRO 0.06
- CHEK 0.05
- MACD
- AYRO 0.01
- CHEK 0.00
- Stochastic Oscillator
- AYRO 67.89
- CHEK 34.17
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.